ReviewCancers2022

From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC).

Susanne Deininger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.